Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Universita di Verona
With
IGEA
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Radiologic confirmation of locally advanced pancreatic cancer by at least contrast enhanced CT of chest and abdomen (with the upper abdomen scanned according to a dedicated 3mm slice multiphase pancreatic tumor protocol), performed maximum 4 weeks prior to the procedure
Cytohistological diagnosis of pancreatic cancer
Age \> 18 and \< 80
Stable disease after chemotherapy (no tumor progression, no oncomarkers (Carbohydrate Antigen 19-9 \[CA 19-9\] or Carcinoembryonic antigen \[CEA\]) increase
Performance Status 0 sec. ECOG (Eastern Cooperative Oncology Group)
Written informed consent
You may not be if
Resectable pancreatic cancer as assessed by multidisciplinary meeting
Stage IV disease
Patients receiving fenitoin, phosphofenitoin or living vaccines
Pregnancy
Progressive disease (either dimensional and not only by stage)
\< 18 years old and \> 80
Clareo Health | Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer
